Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus

Objective: Endoscopic therapy is increasingly being used in the treatment of high-grade intraepithelial neoplasia (HGIN) and mucosal adenocarcinoma (BC) in patients with Barrett’s oesophagus. This report provides 5 year follow-up data from a large prospective study investigating the efficacy and safety of endoscopic treatment in these patients and analysing risk factors for recurrence. Design: Prospective case series. Setting: Academic tertiary care centre. Patients: Between October 1996 and September 2002, 61 patients with HGIN and 288 with BC were included (173 with short-segment and 176 with long-segment Barrett’s oesophagus) from a total of 486 patients presenting with Barrett’s neoplasia. Patients with submucosal or more advanced cancer were excluded. Interventions: Endoscopic therapy. Main outcome measures: Rate of complete remission and recurrence rate, tumour-associated death. Results: Endoscopic resection was performed in 279 patients, photodynamic therapy in 55, and both procedures in 13; two patients received argon plasma coagulation. The mean follow-up period was 63.6 (SD 23.1) months. Complete response (CR) was achieved in 337 patients (96.6%); surgery was necessary in 13 (3.7%) after endoscopic therapy failed. Metachronous lesions developed during the follow-up in 74 patients (21.5%); 56 died of concomitant disease, but none died of BC. The calculated 5 year survival rate was 84%. The risk factors most frequently associated with recurrence were piecemeal resection, long-segment Barrett’s oesophagus, no ablative therapy of Barrett’s oesophagus after CR, time until CR achieved >10 months and multifocal neoplasia. Conclusions: This study showed that endoscopic therapy was highly effective and safe, with an excellent long-term survival rate. The risk factors identified may help stratify patients who are at risk for recurrence and those requiring more intensified follow-up.

[1]  Sm,et al.  EMR for Early Gastric Cancer , 2009 .

[2]  M. Zenker.  Argon plasma coagulation , 2008, GMS Krankenhaushygiene interdisziplinar.

[3]  P. Fockens,et al.  Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients , 2008, Endoscopy.

[4]  P. Fockens,et al.  Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.

[5]  O. Pech,et al.  Endoscopic resection of early oesophageal cancer , 2007, Gut.

[6]  P. Parrilla,et al.  [Surgical treatment of high-grade dysplasia in Barrett's esophagus]. , 2007, Cirugia espanola.

[7]  Kenneth K Wang,et al.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. , 2007, Gastroenterology.

[8]  Bergein F Overholt,et al.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. , 2007, Gastrointestinal endoscopy.

[9]  Shinji Tanaka,et al.  Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. , 2006, Gastrointestinal endoscopy.

[10]  Andrea May,et al.  The Impact of Endoscopic Ultrasound and Computed Tomography on the TNM Staging of Early Cancer in Barrett's Esophagus , 2006, The American Journal of Gastroenterology.

[11]  M. Stolte,et al.  Ablation of Nonneoplastic Barrett's Mucosa Using Argon Plasma Coagulation with Concomitant Esomeprazole Therapy (APBANEX): A Prospective Multicenter Evaluation , 2006, The American Journal of Gastroenterology.

[12]  P. Fockens,et al.  Stepwise Radical Endoscopic Resection Is Effective for Complete Removal of Barrett's Esophagus with Early Neoplasia: A Prospective Study , 2006, The American Journal of Gastroenterology.

[13]  N. Soehendra,et al.  Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video). , 2006, Gastrointestinal endoscopy.

[14]  M. Omata,et al.  Efficacy and Safety of Endoscopic Submucosal Dissection for Tumors of the Esophagogastric Junction , 2006, Endoscopy.

[15]  R. Cestari,et al.  Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. , 2005, World journal of gastroenterology.

[16]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[17]  C. Nwokolo,et al.  Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival , 2005, European journal of gastroenterology & hepatology.

[18]  C. Lightdale,et al.  Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Gossner,et al.  Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. , 2005, Gastrointestinal endoscopy.

[20]  Michael Vieth,et al.  Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). , 2005, Gastrointestinal endoscopy.

[21]  P. Fockens,et al.  Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. , 2005, Gastrointestinal endoscopy.

[22]  J. Goldblum,et al.  Endoscopic Ultrasound Errors in Esophageal Cancer , 2005, The American journal of gastroenterology.

[23]  L. Gossner,et al.  Endoscopic mucosal resection in the stomach using the insulated-tip needle-knife. , 2005, Endoscopy.

[24]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[25]  C J Stoddard,et al.  Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulation , 2004, Alimentary pharmacology & therapeutics.

[26]  Sjoerd M Lagarde,et al.  Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. , 2004, Gastrointestinal endoscopy.

[27]  J. Plukker,et al.  Influence of tumor characteristics on the accuracy of endoscopic ultrasonography in staging cancer of the esophagus and esophagogastric junction. , 2004, Endoscopy.

[28]  G. Monges,et al.  Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. , 2004, Endoscopy.

[29]  H. Sue-Ling,et al.  Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer , 2004, The British journal of surgery.

[30]  E Günter,et al.  Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial , 2004, Gut.

[31]  Robert E Harbaugh,et al.  Surgeon Volume and Operative Mortality in the United States. , 2004, Neurosurgery.

[32]  N. Soehendra,et al.  Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. , 2003, Gastrointestinal endoscopy.

[33]  L. Gossner,et al.  Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach , 2002, European journal of gastroenterology & hepatology.

[34]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[35]  Dennis M. Riehle,et al.  Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. , 2001, Gastroenterology.

[36]  A. Sonnenberg,et al.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.

[37]  S. Yoshida,et al.  Endoscopic mucosal resection for treatment of early gastric cancer , 2001, Gut.

[38]  L. Aaltonen,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[39]  Gary Longton,et al.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.

[40]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. , 1998, Gastroenterology.

[41]  K. Hosokawa,et al.  [Recent advances in endoscopic mucosal resection for early gastric cancer]. , 1998, Gan to kagaku ryoho. Cancer & chemotherapy.

[42]  A. Hölscher,et al.  Early adenocarcinoma in Barrett's oesophagus , 1997, The British journal of surgery.

[43]  R C Heading,et al.  Barrett's oesophagus. , 1987, British medical journal.

[44]  M. Hawn.  Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients , 2008 .

[45]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[46]  Prateek Sharma.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. , 2002, Gastrointestinal endoscopy.

[47]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[48]  J. Seitz,et al.  Esophageal cancer resection in the elderly. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.